Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||
| DOI | 10.1002/14651858.CD016208 | ||
| Año | 2025 | ||
| Tipo |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Primary To assess the comparative benefits and harms of immunomodulators and immunosuppressants for people with generalised myasthenia gravis through a network meta-analysis. Secondary To estimate the relative ranking of immunomodulators and immunosuppressants according to their effects.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Varela, Lucia B. | - |
Hospital Italiano de Buenos Aires - Argentina
|
| 2 | Meza, Nicolás | - |
Universidad de Valparaíso - Chile
|
| 3 | Escobar Liquitay, Camila Micaela | - |
Hospital Italiano de Buenos Aires - Argentina
|
| 4 | Díaz Menai, Samanta | - |
Hospital Italiano de Buenos Aires - Argentina
|
| 5 | Franco, Juan | - |
Heinrich-Heine-Universität Düsseldorf - Alemania
|
| 6 | Garegnani, Luis | - |
Hospital Italiano de Buenos Aires - Argentina
|
| Fuente |
|---|
| Charité – Universitätsmedizin Berlin |
| McGill University |
| Center for Stroke Research Berlin |
| Cochrane Central Production Service |
| Agradecimiento |
|---|
| The following people conducted the editorial process for this article: Sign-off Editor (final editorial decision): Colin Chalk, MD, CM FRCPC, Department of Neurology & Neurosurgery, McGill University, Montreal, Canada; Managing Editor (selected peer reviewers, provided editorial guidance to authors, edited the article): Jenny Bellorini, Cochrane Central Editorial Service; Editorial Assistant (conducted editorial policy checks, collated peer-reviewer comments, and supported the editorial team): Cynthia Stafford, Cochrane Central Editorial Service; Copy Editor (copy editing and production): Lisa Winer, Cochrane Central Production Service; Peer reviewers (provided comments and recommended an editorial decision): Andreas Meisel, Department of Neurology with Experimental Neurology, Integriertes Myasthenie Zentrum, Neuroscience Clinical Research Center, Center for Stroke Research Berlin, Charit\u00E9 Universit\u00E4tsmedizin Berlin, Berlin, Germany (clinical/content review); Nuala Livingstone, Cochrane Evidence Production and Methods Directorate (methods review); Jo Platt, Central Editorial Information Specialist (search review). One additional peer reviewer provided consumer peer review but chose not to be publicly acknowledged. Sign-off Editor (final editorial decision): Colin Chalk, MD, CM FRCPC, Department of Neurology & Neurosurgery, McGill University, Montreal, Canada; Managing Editor (selected peer reviewers, provided editorial guidance to authors, edited the article): Jenny Bellorini, Cochrane Central Editorial Service; Editorial Assistant (conducted editorial policy checks, collated peer-reviewer comments, and supported the editorial team): Cynthia Stafford, Cochrane Central Editorial Service; Copy Editor (copy editing and production): Lisa Winer, Cochrane Central Production Service; Peer reviewers (provided comments and recommended an editorial decision): Andreas Meisel, Department of Neurology with Experimental Neurology, Integriertes Myasthenie Zentrum, Neuroscience Clinical Research Center, Center for Stroke Research Berlin, Charit\u00E9 Universit\u00E4tsmedizin Berlin, Berlin, Germany (clinical/content review); Nuala Livingstone, Cochrane Evidence Production and Methods Directorate (methods review); Jo Platt, Central Editorial Information Specialist (search review). One additional peer reviewer provided consumer peer review but chose not to be publicly acknowledged. |